TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
STOK

Stoke Therapeutics Inc

Healthcare · Biotechnology

25.60$ -1.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement STOK
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – +313.5% -29.2% +316.3% +404.5%
– +89.4% +110.3% +328.0% +15.8% +58.5% +33.8% -6.1% –
– – – – – – -29.2% +316.3% +404.5%
– +132.7% +183.9% +35.5% +68.2% +43.7% +5.6% +8.4% +54.7%
– +125.5% +170.2% +75.0% +53.0% +22.0% +6.2% +18.1% +37.5%
– +130.1% +179.1% +48.7% +62.3% +35.7% +5.8% +11.6% +48.6%
– – – – – – – – –
– – – – – +2,501.7% +217.4% +27.6% -99.9%
– – – – – – – – –
– – -1,561.9% – – – – -2,050.9% –
– – – – – – – – –
– – – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?